Quality project to evaluate and validate the FAST-O Rating Scale - FAST-O
Study identifier:NIS-NSE-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Quality project to Evaluate and Validate the FAST-O Rating Scale (Fast ASessment in acute Treatment of psychosis-Observation)
Medical condition
Acute Psychotic Symptoms
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
111
Study type
Observational
Age
N/A
Date
Study Start Date: 01 May 2009
Primary Completion Date: -
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| psychotic patients psychotic patients, acute ward, symptom rating scale. | - |
Contacts
Investigators
Principal Investigator
Eva Dencker Vansvik
Medical Department
